Clinical Trial Update: AI-Guided Sarcopenia Risk Assessment and Detection [NA]

View source ↗

Summary

An AI-guided trial led by Tel Aviv University aims to assess and detect sarcopenia risk; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Snippet

Sponsor: Tel Aviv University | Conditions: Sarcopenia, Age-related Muscle Loss | NA | Status: ACTIVE_NOT_RECRUITING